HPV DNA test

OTHER4 trials

Sponsors

Becton, Dickinson and Company, International Agency for Research on Cancer, Timser SAPI de CV

Conditions

AGUSASC-USAtypical Glandular Cells of Uncertain SignificanceAtypical Squamous Cell of Undetermined SignificanceCIN 1CIN 2CIN 3Cervical Cancer

Phase 3

The Study for the Cervical Cancer Screening and Treatment Algorithms Study Using HPV Testing in Africa

Active, not recruitingNCT04794660

International Agency for Research on CancerHPV Infection

Start: 2019-10-01End: 2025-10-01Target: 1500Updated: 2024-03-13

Unknown Phase

Intended Use Study of the BD SurePath Plus™ Pap

TerminatedNCT01234480

Becton, Dickinson and CompanyNeoplasms, Neoplasms by Histologic Type, Neoplasms, Glandular and Epithelial +4

Start: 2010-09-30End: 2012-08-31Updated: 2023-05-16

Comparison Of Cytology And Molecular Screening For Detecting Cervical Reactive Cellular Changes In General Population

WithdrawnNCT07211204

Timser SAPI de CVAGUS, ASC-US, Atypical Glandular Cells of Uncertain Significance +6

Start: 2026-02-27End: 2026-02-27Updated: 2026-03-03

Comparison Between Liquid-Based Cytology And Molecular Screening For Detecting Precursor Lesions and Cervical Cancer

RecruitingNCT07480902

Timser SAPI de CVI) Atypical Squamous Cells of Undetermined Significance (ASC-US), II) Atypical Glandular Cells of Uncertain Significance (AGUS), III) Cervical Intraepithelial Neoplasia (CIN), CIN-1, CIN-2, CIN-3 +3

Start: 2026-02-03End: 2026-06-01Target: 558Updated: 2026-03-18